Peter Gribling

1.9k total citations
12 papers, 1.0k citations indexed

About

Peter Gribling is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy. According to data from OpenAlex, Peter Gribling has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Immunology and Allergy. Recurrent topics in Peter Gribling's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Immune Response and Inflammation (3 papers) and Cell Adhesion Molecules Research (3 papers). Peter Gribling is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Immune Response and Inflammation (3 papers) and Cell Adhesion Molecules Research (3 papers). Peter Gribling collaborates with scholars based in United States, Italy and France. Peter Gribling's co-authors include Wyne P. Lee, Lauri Diehl, Kathy Nguyen, Richard A.D. Carano, Jennine Cornelius, Wei Lin, Yanmei Lu, Thanhvien Tran, Shiming Ye and Qian Gong and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Peter Gribling

12 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Gribling United States 12 595 299 215 190 174 12 1.0k
Debbie L. Hardie United Kingdom 18 603 1.0× 272 0.9× 320 1.5× 141 0.7× 232 1.3× 34 1.2k
Christian Kneitz Germany 17 585 1.0× 196 0.7× 184 0.9× 247 1.3× 206 1.2× 29 1.1k
Seisuke Takemura Japan 8 787 1.3× 331 1.1× 106 0.5× 529 2.8× 234 1.3× 14 1.3k
Bärbel Reininger Austria 17 1.0k 1.8× 207 0.7× 167 0.8× 350 1.8× 134 0.8× 22 1.7k
Anne H. Cutler United States 11 1.3k 2.2× 320 1.1× 188 0.9× 445 2.3× 172 1.0× 11 1.9k
Boutahar Bendaoud France 17 527 0.9× 279 0.9× 109 0.5× 397 2.1× 89 0.5× 34 1.1k
T. Sasazuki Japan 18 572 1.0× 122 0.4× 268 1.2× 150 0.8× 163 0.9× 36 1.2k
Teresa Owen United States 12 895 1.5× 288 1.0× 308 1.4× 524 2.8× 262 1.5× 14 1.5k
M Kyogoku Japan 16 498 0.8× 131 0.4× 240 1.1× 262 1.4× 103 0.6× 41 1.0k
Manuel J. Del Rey Spain 18 368 0.6× 99 0.3× 320 1.5× 263 1.4× 254 1.5× 49 1.2k

Countries citing papers authored by Peter Gribling

Since Specialization
Citations

This map shows the geographic impact of Peter Gribling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Gribling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Gribling more than expected).

Fields of papers citing papers by Peter Gribling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Gribling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Gribling. The network helps show where Peter Gribling may publish in the future.

Co-authorship network of co-authors of Peter Gribling

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Gribling. A scholar is included among the top collaborators of Peter Gribling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Gribling. Peter Gribling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
He, Jeannie Q., Kenneth J. Katschke, Peter Gribling, et al.. (2012). CRIg mediates early Kupffer cell responses to adenovirus. Journal of Leukocyte Biology. 93(2). 301–306. 35 indexed citations
2.
Chiang, Eugene Y., Ganesh Kolumam, Xin Yu, et al.. (2009). Targeted depletion of lymphotoxin-α–expressing TH1 and TH17 cells inhibits autoimmune disease. Nature Medicine. 15(7). 766–773. 142 indexed citations
3.
Katschke, Kenneth J., Karim Y. Helmy, Micah Steffek, et al.. (2007). A novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritis. The Journal of Experimental Medicine. 204(6). 1319–1325. 76 indexed citations
4.
Gong, Qian, Qinglin Ou, Shiming Ye, et al.. (2005). Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy. The Journal of Immunology. 174(2). 817–826. 423 indexed citations
5.
Seshasayee, Dhaya, Hua Wang, Wyne P. Lee, et al.. (2004). A Novel in Vivo Role for Osteoprotegerin Ligand in Activation of Monocyte Effector Function and Inflammatory Response. Journal of Biological Chemistry. 279(29). 30202–30209. 56 indexed citations
6.
Barck, Kai, Wyne P. Lee, Lauri Diehl, et al.. (2004). Quantification of cortical bone loss and repair for therapeutic evaluation in collagen‐induced arthritis, by micro–computed tomography and automated image analysis. Arthritis & Rheumatism. 50(10). 3377–3386. 54 indexed citations
7.
Hoke, David E., Reina E. Mebius, Noël Dybdal, et al.. (1995). Selective modulation of the expression of L-selectin ligands by an immune response. Current Biology. 5(6). 670–678. 49 indexed citations
8.
Gribling, Peter, et al.. (1995). A P-selectin-immunoglobulin G chimera is protective in a rabbit ear model of ischemia-reperfusion. Surgery. 117(4). 458–465. 15 indexed citations
9.
Moran, Paul, Helen Beasley, Emily B. Martin, et al.. (1992). Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo. The Journal of Immunology. 149(5). 1736–1743. 92 indexed citations
10.
Ferraiolo, Bobbe L., et al.. (1988). Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.. Drug Metabolism and Disposition. 16(2). 270–275. 43 indexed citations
11.
Lie, Yolanda, et al.. (1988). Reduced mortality in murine cytomegalovirus infected mice following prophylactic murine interferon-γ treatment. Antiviral Research. 10(1-3). 27–39. 20 indexed citations
12.
Jorgenson, T.A., et al.. (1975). Study of the mutagenic potential of nitrilotriacetic acid (NaCaNTA) in mice by the translocation test. Mutation Research/Environmental Mutagenesis and Related Subjects. 31(5). 337–338. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026